Literature DB >> 2982413

Do vanadate polyanions inhibit phosphotransferase enzymes?

D W Boyd, K Kustin, M Niwa.   

Abstract

Decavanadate inhibits hexokinase, adenylate kinase and phosphofructokinase; neither mono-, tri nor tetrameric vanadate anion is an inhibitor. Decavanadate inhibits phosphofructokinase obtained from bacterial and protistic sources. No form of vanadium(V) anion inhibits galacto-, glycero-, pyruvate and creatine kinase, or inorganic pyrophosphatase. Decavanadate appears to be a non-competitive inhibitor of both hexokinase substrates.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982413     DOI: 10.1016/0167-4838(85)90235-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Vanadium oxoanions and cAMP-dependent protein kinase: an anti-substrate inhibitor.

Authors:  S Pluskey; M Mahroof-Tahir; D C Crans; D S Lawrence
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

2.  Antagonistic regulation of native Ca2+- and ATP-sensitive cation channels in brain capillaries by nucleotides and decavanadate.

Authors:  László Csanády; Vera Adam-Vizi
Journal:  J Gen Physiol       Date:  2004-06       Impact factor: 4.086

3.  A soluble 5'-nucleotidase in rat kidney. Stimulation by decavanadate.

Authors:  M Le Hir
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

4.  A disposable alkaline phosphatase-based biosensor for vanadium chronoamperometric determination.

Authors:  Ana Lorena Alvarado-Gámez; María Asunción Alonso-Lomillo; Olga Domínguez-Renedo; María Julia Arcos-Martínez
Journal:  Sensors (Basel)       Date:  2014-02-24       Impact factor: 3.576

5.  Studies of the Effectiveness of Bisphosphonate and Vanadium-Bisphosphonate Compounds In Vitro against Axenic Leishmania tarentolae.

Authors:  Amy T Christensen; Craig C McLauchlan; Anne Dolbecq; Pierre Mialane; Marjorie A Jones
Journal:  Oxid Med Cell Longev       Date:  2016-02-29       Impact factor: 6.543

Review 6.  Polyoxometalates as Potential Next-Generation Metallodrugs in the Combat Against Cancer.

Authors:  Aleksandar Bijelic; Manuel Aureliano; Annette Rompel
Journal:  Angew Chem Int Ed Engl       Date:  2018-10-12       Impact factor: 15.336

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.